A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC

32:15 |

Related Videos

Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers

1:03:39

Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers

Optimal SCLC Care With Established and Innovative Therapies

1:27:09

Optimal SCLC Care With Established and Innovative Therapies

Beyond the Horizon in Gastric Cancer: Updated Evidence on How Systemic Therapies Are Redefining Care

1:06:54

Beyond the Horizon in Gastric Cancer: Updated Evidence on How Systemic Therapies Are Redefining Care

Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma

1:23:36

Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma

Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens

49:39

Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens

The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals

57:49

The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals

Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer

59:12

Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer

Building on the Immunotherapy Foundation for Head and Neck Cancer

1:16:37

Building on the Immunotherapy Foundation for Head and Neck Cancer

Expanding the Benefits of Immuno-Oncology Through Novel Rational Targets and Combinations

39:06

Expanding the Benefits of Immuno-Oncology Through Novel Rational Targets and Combinations

Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine

1:06:30

Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine

REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated VTE

36:08

REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated VTE

Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies

56:08

Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies

Watch Dr. Ramalingam discuss the latest #NSCLC updates from #WCLC24 - https://bit.ly/24Stage3LungY

1:01:05

Watch Dr. Ramalingam discuss the latest #NSCLC updates from #WCLC24 - https://bit.ly/24Stage3LungY

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer

57:18

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer

Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY

1:38:45

Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY

Decoding Biomarker Testing and Targeted Therapy in NSCLC

1:25:15

Decoding Biomarker Testing and Targeted Therapy in NSCLC

Protocols for HER2-Expressing GI Cancers: Refining BTC and GEA Care With Targeted Agents

1:01:07

Protocols for HER2-Expressing GI Cancers: Refining BTC and GEA Care With Targeted Agents

Catalysts for Change in Gastric & GEJ Cancer

1:35:13

Catalysts for Change in Gastric & GEJ Cancer

Personalizing Treatment Decisions in HER2-Altered Breast Cancer

1:31:37

Personalizing Treatment Decisions in HER2-Altered Breast Cancer

Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer

59:06

Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer